Glyconics: Infrared Spectroscopy To Detect And Manage COPD
Chronic obstructive pulmonary disease remains a particularly difficult disease to accurately diagnose, with little improvement over the last 30 years. UK-based Glyconics Ltd. hopes to reliably detect COPD with an easy, five-minute, in-office procedure that uses a sputum sample to identify a handful of proprietary biomarkers specific for the disease.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from fellow Indian firm Glenmark.
Sandoz has launched an awareness campaign under the banner of “Ask For Generics” in the US. The initiative is aiming to educate stakeholders on the benefits of generics and their quality, safety and efficacy.
European Commission proposals for strengthening intellectual property protections in the EU, particularly the supplementary protection certificate (SPC) system, have been broadly welcomed by Europe’s brand industry. But the medical NGO, MSF, says the SPC proposals run counter to the commission’s own efforts to improve access to medicines.